Cargando…

Extensive molecular screening for hereditary non-polyposis colorectal cancer

The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieumegard, B, Grandjouan, S, Sabourin, J-C, Bihan, M-L Le, Lefrère, I, Bellefqih, Pignon, J-P, Rougier, P, Lasser, P, Bénard, J, Couturier, D, Bressac-de Paillerets, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374417/
https://www.ncbi.nlm.nih.gov/pubmed/10732761
http://dx.doi.org/10.1054/bjoc.1999.1014
_version_ 1782154448562290688
author Dieumegard, B
Grandjouan, S
Sabourin, J-C
Bihan, M-L Le
Lefrère, I
Bellefqih
Pignon, J-P
Rougier, P
Lasser, P
Bénard, J
Couturier, D
Bressac-de Paillerets, B
author_facet Dieumegard, B
Grandjouan, S
Sabourin, J-C
Bihan, M-L Le
Lefrère, I
Bellefqih
Pignon, J-P
Rougier, P
Lasser, P
Bénard, J
Couturier, D
Bressac-de Paillerets, B
author_sort Dieumegard, B
collection PubMed
description The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates for germline mutational analysis. We studied three groups of patients, HNPCC kindreds fulfilling the International Collaborative Group (ICG) criteria (n = 10), families in which at least one of the criteria was not satisfied (n = 7) and sporadic colorectal cancer (CRC) diagnosed before the age of 50 (n = 17). We searched for microsatellite instability (MSI), presence of hMSH2 and hMLH1 germline mutations, expression of hMSH2, hMLH1 and p53 proteins in tumoural tissue samples by immunostaining. Fifteen out of 17 (88%) of HNPCC and incomplete HNPCC cases were MSI and eight pathogenic germline mutations in hMSH2 or hMLH1 were detected in these two groups (53%). All the 17 early-onset sporadic cases were MSS and no germline mutations were detected among the seven investigated cases. Thirteen out of 15 (81%) familial cases were MSI and p53 protein-negative, whereas 13/14 (93%) sporadic cases were MSS and strongly p53 protein-positive. This extensive molecular investigation shows that simple tests such as MS study combined with hMSH2 and hMLH1 protein immunostaining performed on tumoural tissues may provide valuable information to distinguish between familial, and probably hereditary, and sporadic CRC cases. © 2000 Cancer Research Campaign
format Text
id pubmed-2374417
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23744172009-09-10 Extensive molecular screening for hereditary non-polyposis colorectal cancer Dieumegard, B Grandjouan, S Sabourin, J-C Bihan, M-L Le Lefrère, I Bellefqih Pignon, J-P Rougier, P Lasser, P Bénard, J Couturier, D Bressac-de Paillerets, B Br J Cancer Regular Article The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates for germline mutational analysis. We studied three groups of patients, HNPCC kindreds fulfilling the International Collaborative Group (ICG) criteria (n = 10), families in which at least one of the criteria was not satisfied (n = 7) and sporadic colorectal cancer (CRC) diagnosed before the age of 50 (n = 17). We searched for microsatellite instability (MSI), presence of hMSH2 and hMLH1 germline mutations, expression of hMSH2, hMLH1 and p53 proteins in tumoural tissue samples by immunostaining. Fifteen out of 17 (88%) of HNPCC and incomplete HNPCC cases were MSI and eight pathogenic germline mutations in hMSH2 or hMLH1 were detected in these two groups (53%). All the 17 early-onset sporadic cases were MSS and no germline mutations were detected among the seven investigated cases. Thirteen out of 15 (81%) familial cases were MSI and p53 protein-negative, whereas 13/14 (93%) sporadic cases were MSS and strongly p53 protein-positive. This extensive molecular investigation shows that simple tests such as MS study combined with hMSH2 and hMLH1 protein immunostaining performed on tumoural tissues may provide valuable information to distinguish between familial, and probably hereditary, and sporadic CRC cases. © 2000 Cancer Research Campaign Nature Publishing Group 2000-02 /pmc/articles/PMC2374417/ /pubmed/10732761 http://dx.doi.org/10.1054/bjoc.1999.1014 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Dieumegard, B
Grandjouan, S
Sabourin, J-C
Bihan, M-L Le
Lefrère, I
Bellefqih
Pignon, J-P
Rougier, P
Lasser, P
Bénard, J
Couturier, D
Bressac-de Paillerets, B
Extensive molecular screening for hereditary non-polyposis colorectal cancer
title Extensive molecular screening for hereditary non-polyposis colorectal cancer
title_full Extensive molecular screening for hereditary non-polyposis colorectal cancer
title_fullStr Extensive molecular screening for hereditary non-polyposis colorectal cancer
title_full_unstemmed Extensive molecular screening for hereditary non-polyposis colorectal cancer
title_short Extensive molecular screening for hereditary non-polyposis colorectal cancer
title_sort extensive molecular screening for hereditary non-polyposis colorectal cancer
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374417/
https://www.ncbi.nlm.nih.gov/pubmed/10732761
http://dx.doi.org/10.1054/bjoc.1999.1014
work_keys_str_mv AT dieumegardb extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT grandjouans extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT sabourinjc extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT bihanmlle extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT lefrerei extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT bellefqih extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT pignonjp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT rougierp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT lasserp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT benardj extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT couturierd extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer
AT bressacdepailleretsb extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer